Learn
One immune response: see mechanisms in acts — not “result numbers”.
The learn track uses biologically careful storytelling for exhibits and teaching. It shares modules with research mode, but never claims a sandbox demo is a public-data-aligned result.
§ 1
Popular mode vs research mode
| Axis | Popular | Research |
|---|---|---|
| Goal | Phenomenologically sound story | Pinned params, public data, intervals, reproducible configs |
| Parameters | Teaching defaults (replaceable) | Calibrated version + UQ |
| Outputs | Narrative & schematics | Report + replay evidence chain |
| Forbidden | Calling demos “validated results” | Claiming a use without COU |
§ 2
Story acts (schematic)
- Act ISchematic
Invasion & alarm
Pathogen enters; infected cells raise IFN-like alarms; local fields rise.
- Act IISchematic
Innate vanguard
NK / neutrophils respond quickly, limiting early spread while stressing tissue.
- Act IIISchematic
Adaptive relay
CTL and antibody pathways take over; clearance efficiency rises.
- Act IVSchematic
Balance & cost
Inflammation and suppression trade off — not a “perfect clear” myth.
- Side · TumorSchematic
Suppression & checkpoints
Microenvironment suppression and PD-1 narratives as mechanism contrast only.
§ 3
Acts ↔ modules
| Act | Modules (examples) |
|---|---|
| Invasion & alarm | infection_replication · ifn_alarm |
| Innate vanguard | nk_kill · neutrophil_axis |
| Adaptive relay | ctl_effect · antibody_ode |
| Balance & cost | inflammation_field · suppression |
| Tumor side | tumor_growth · checkpoint_pd1 |
§ 4
Read with care
Popular narrative is not a care pathway, not individual-patient specific, and not dosing advice.
Without data binding, demos are teaching intuition only; research mode requires COU and audit trails.